A retrospective study on the incidence, management and risk factors of skin rash in patients with advanced prostate cancer in Japan.

ABSTRACT:

Background

Worldwide, prostate cancer (PC) is the second most diagnosed cancer and the fifth leading cause of cancer death in men. Hormonal therapies, commonly used for PC, are associated with a range of treatment-emergent adverse events (TEAEs). The population from Japan seems to be at higher risk of developing TEAEs of skin rash compared to the overall global population. This study was conducted to get a better insight into the incidence, management, and risk factors for skin rash during active treatment for advanced PC in Japan.

Methods

A retrospective cohort of PC patients was identified and subsequently categorized, into non-metastatic and metastatic castration-resistant prostate cancer patients (nmCRPC and mCRPC), and metastatic castration-naïve prostate cancer patient

SUBMITTER: De Moor R 

PROVIDER: S-EPMC10148545 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature